Continuum Advisory’s Enovis ENOV Stock Holding History

Continuum Advisory’s Portfolio ENOV Stock Details ENOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10	Closed	-$511	–	1720
2024 Q1	$511	Buy	+10	New	+$598	﹤0.01%	1602

Other funds holding ENOV

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

CCM

Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return

Continuum Advisory's ENOV Position: Q2 2024 in Review

Continuum Advisory sold out of Enovis (ENOV) in Q2 2024, closing a stake of 10 shares — an estimated $511 sold.

Continuum Advisory first reported a position in ENOV in Q1 2024 and held it in 1 quarter. The position peaked at $511 in Q1 2024. 281 funds tracked by Wall St. Rank hold ENOV as of Q2 2024.

Continuum Advisory reported no remaining Enovis position as of Q2 2024 after selling out during the quarter.
Continuum Advisory sold 10 Enovis shares in Q2 2024, an estimated $511.
Continuum Advisory first reported a position in Enovis in Q1 2024 and held it in 1 quarter.
Continuum Advisory's Enovis position peaked at $511 in Q1 2024.
281 funds tracked by Wall St. Rank held Enovis as of Q2 2024.

Based on Continuum Advisory's 13F filing for Q2 2024, filed 19 Jul 2024.